FDA Approved: XELODA — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for XELODA (capecitabine) from H2-Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

SUPPL AP for XELODA (CAPECITABINE)